Patras, Greece

Konstantinos Barlos

This inventor holds 1 USPTO granted patent and 8 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Chemical & Biopharmaceutical Laboratories of Patras Sa. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Konstantinos Barlos: Innovator in Insulin-Like Peptides

Introduction

Konstantinos Barlos is a notable inventor based in Patra, Greece. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of insulin-like peptides. His work has implications for pharmaceutical applications, showcasing the potential for innovative treatments.

Latest Patents

Barlos holds a patent for "Insulin-like peptides." This patent describes the preparation of insulin-like peptides, chimeric insulin-like peptides, and their derivatives through the random combination of their chains A and B. The patent also outlines the pharmaceutical applications of the products obtained from this innovative process. He has 1 patent to his name.

Career Highlights

Konstantinos Barlos is associated with the Chemical & Biopharmaceutical Laboratories of Patras S.A. His work at this institution has allowed him to explore and develop new biopharmaceutical products that can potentially improve health outcomes.

Collaborations

Barlos has collaborated with notable colleagues, including Kleomenis Barlos and Kleomenis K Barlos. These collaborations have likely contributed to the advancement of his research and the successful development of his patented innovations.

Conclusion

Konstantinos Barlos is a distinguished inventor whose work in insulin-like peptides represents a significant advancement in biopharmaceuticals. His contributions are paving the way for future innovations in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…